Lv1
28 积分 2025-07-11 加入
Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase-Targeted Approaches
3小时前
待确认
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
5个月前
已完结
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
6个月前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
6个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
11个月前
已完结
Targeted Delivery of Rolipram to the Liver Using Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease
6个月前
已采纳
Integrating soil biofilms: A holistic approach to understanding their role in soil health
11个月前
已采纳
Risk factors for lymphedema and method of assessment in endometrial cancer: a prospective longitudinal multicenter study
11个月前
已采纳
Risk factors for lymphedema and method of assessment in endometrial cancer: A prospective longitudinal multicenter study
11个月前
已采纳
皖公网安备34019202002308
